StemCells, Inc. Appoints Greg Schiffman as Chief Financial Officer
November 14, 2013
NEWARK, Calif. -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, today announced that Greg Schiffman will join its executive team as Chief Financial Officer and Executive Vice President of Finance, effective January 1, 2014. In his new role, Mr. Schiffman will be responsible [...]
Perten receives NTEP certification for IM 9500
November 14, 2013
Perten Instruments receives NTEP certification for whole grain NIR analysis of moisture, protein, oil and test weight Industry standard NIR transmittance technology employed for accurate, timely analysis. Perten Instruments announced that its IM 9500 Whole Grain NIR has received Certificate of Conformance for National Type Equipment Program (NTEP). NTEP approval means that the IM 9500 [...]
GENAPSYS™, INC. RAISES $37M TO COMMERCIALIZE NEXT GENERATION SEQUENCING PLATFORM
November 14, 2013
Redwood City, California –– GenapSys™, Inc. (GenapSys), a provider of Next Generation Sequencing (NGS) systems, today announced it has raised $37M to commercialize the GENIUS™ 110 system (Gene Electronic Nano-Integrated Ultra-Sensitive), a fully integrated DNA Sequencing system for the rapidly evolving NGS market. The Series B financing includes new investors Yuri Milner, Stanford StartX Fund, [...]
November 14, 2013
FREMONT, Calif. — WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today its financial results for the third quarter ended September 30, 2013. Total revenue for the third quarter of 2013 was $390,000, up 121% from $177,000 in the third quarter of 2012. Net loss for the third quarter of 2013 was $11.0 million, compared to a [...]
November 14, 2013
Jena, Germany — Endress+Hauser (Deutschland) AG Co. KG (“E+H KG”) concluded an option agreement with the founder and Chief Executive Officer of Analytik Jena AG, Klaus Berka, and with the Thüringer Industriebeteiligungs-GmbH & Co. KG (“TIB”) today. Through it, the contract parties have the right to purchase or transfer the shares of Analytik Jena AG [...]
November 14, 2013
SANTA BARBARA, CALIFORNIA - Wyatt Technology Corporation, the world leader in absolute macromolecular characterization instrumentation and software, today announced that its technology is being used by the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) to make advancements in tackling specific problems in human health and disease such as understanding different biophysical processes, including [...]
BIOMAX INFORMATICS investing big to develop a knowledge solution for mental health
November 14, 2013
PLANEGG, Germany -- Biomax Informatics AG will invest nearly 1 million Euro over the next 4 years to transfer its successful systems medicine approach from respiratory and chronic diseases to mental health. The European Commission is co-financing this step with €650,000 as part of the METSY project. In the project, Biomax will provide the knowledge [...]
Cole-Parmer Introduces the Latest Technology in Mixers with the Intelli-Mixer RM-2
November 14, 2013
Vernon Hills, IL -- Powered by V-Spin technology, the Intelli-Mixer RM-2 from Cole-Parmer employs the newest science to expand mixing options as well as replicate user motions. The multifunctional mixer features 15 mixing, 12 rocking, four blotting, and three custom modes to deliver exceptional mixing performance. The mixer maximizes efficiency by carrying out a variety [...]
LUMENSE RAISES SERIES B, PLANS TO BRING ITS REAL-TIME SENSOR PLATFORM TO PRODUCTION
November 14, 2013
Atlanta, GA –– Lumense, an Atlanta-based developer of real-time quality control sensors capable of continuously measuring the contents of gases and liquids, has raised a Series B round led by the GRA Venture Fund and The Coca-Cola Company. The funds will be used to move the company’s flexible and scalable sensor platform, and its initial [...]
PCR from Whole Blood, Simplified
November 14, 2013
CINCINNATI -- Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the MyTaqTM Blood-PCR Kit, developed for fast, highly-specific PCR direct from whole blood samples. Based on the proven MyTaqTM HS DNA polymerase, in combination with a novel, red-colored, buffer system; the new Bioline [...]

